EPHB4 and melanoma: Indeed, inhibition of the physiological tumor-endothelial ephrinB2–EphB4 interaction led to increased spinal bone metastasis, earlier appearance of hind-limb locomotion deficits and shorter survival in a systemic melanoma metastasis model.